Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,158 JPY | -0.24% | +3.36% | +2.57% |
25/06 | US CDC alerts healthcare providers of increase in dengue cases | RE |
25/06 | Takeda's Cancer Drug Gets European Commission Approval | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.57% | 4.07TCr | |
+54.61% | 81TCr | |
+43.79% | 64TCr | |
-6.33% | 35TCr | |
+20.62% | 33TCr | |
+10.44% | 30TCr | |
+17.98% | 25TCr | |
+2.62% | 22TCr | |
+12.71% | 22TCr | |
+8.61% | 17TCr |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda's Soticlestat Shows Promising Secondary Outcomes in Phase 3 Studies for Dravet and Lennox-Gastaut Syndromes